(Q37203402)

18 August 2017

1 reference

title

Neuroimaging and transcranial ultrasonography in Parkinson's disease (English)

1 reference

18 August 2017

0 references

1 reference

Shyamal H Mehta

1

1 reference

18 August 2017

John C Morgan

series ordinal

2

1 reference

18 August 2017

Kapil D Sethi

series ordinal

3

1 reference

18 August 2017

language of work or name

1 reference

1 July 2008

1 reference

Current Neurology and Neuroscience Reports

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

297-303

1 reference

Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0046-6

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0046-6

The role of radiotracer imaging in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0046-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0046-6

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0046-6

Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-008-0046-6

Predictive value of transcranial sonography in the diagnosis of Parkinson's disease

21 January 2018

1 reference

12 December 2020

Comparison of 123I-IBZM SPECT and 11C-raclopride PET findings in patients with parkinsonism

1 reference

12 December 2020

Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA.

1 reference

12 December 2020

PET tracers for imaging of the dopaminergic system.

1 reference

12 December 2020

Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.

1 reference

12 December 2020

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

1 reference

12 December 2020

Plasticity of the nigropallidal pathway in Parkinson's disease.

1 reference

12 December 2020

Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study

1 reference

12 December 2020

Transcranial brain parenchyma sonography in movement disorders: state of the art.

1 reference

12 December 2020

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

1 reference

12 December 2020

Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.

1 reference

12 December 2020

Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease

1 reference

12 December 2020

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

1 reference

12 December 2020

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

12 December 2020

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease

1 reference

12 December 2020

Endogenous dopamine release after pharmacological challenges in Parkinson's disease.

1 reference

12 December 2020

Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.

1 reference

12 December 2020

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

1 reference

12 December 2020

Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo

1 reference

12 December 2020

Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease

1 reference

12 December 2020

Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity

1 reference

12 December 2020

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease

1 reference

12 December 2020

Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride

1 reference

12 December 2020

New developments of brain imaging for Parkinson's disease and related disorders.

1 reference

12 December 2020

Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias

1 reference

12 December 2020

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis

1 reference

12 December 2020

Diagnostic value of asymmetric striatal D2 receptor upregulation in Parkinson's disease: an [123I]IBZM and [123I]FP-CIT SPECT study.

1 reference

12 December 2020

Microglial activation and dopamine terminal loss in early Parkinson's disease

1 reference

12 December 2020

Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study

1 reference

12 December 2020

Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.

1 reference

12 December 2020

Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone

1 reference

12 December 2020

Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.

1 reference

12 December 2020

Neuroimaging and therapeutics in movement disorders

1 reference

12 December 2020

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

1 reference

12 December 2020

Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study.

1 reference

12 December 2020

Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism

1 reference

12 December 2020

Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.

1 reference

12 December 2020

Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease.

1 reference

12 December 2020

10.1007/S11910-008-0046-6

Identifiers

DOI

1 reference

18 August 2017

1 reference